VALENTE, SERAFINA
 Distribuzione geografica
Continente #
NA - Nord America 12.100
EU - Europa 9.595
AS - Asia 6.369
SA - Sud America 1.464
AF - Africa 410
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 29.957
Nazione #
US - Stati Uniti d'America 11.843
IT - Italia 3.297
RU - Federazione Russa 2.410
SG - Singapore 2.060
CN - Cina 1.472
BR - Brasile 1.216
IE - Irlanda 840
VN - Vietnam 818
GB - Regno Unito 757
HK - Hong Kong 561
DE - Germania 530
FR - Francia 435
KR - Corea 381
FI - Finlandia 338
SE - Svezia 305
BD - Bangladesh 297
IN - India 242
ZA - Sudafrica 217
NL - Olanda 214
CA - Canada 139
ES - Italia 86
MX - Messico 82
AR - Argentina 78
PL - Polonia 70
IQ - Iraq 64
JP - Giappone 62
UA - Ucraina 59
ID - Indonesia 57
AT - Austria 55
EC - Ecuador 46
TR - Turchia 44
KE - Kenya 42
CI - Costa d'Avorio 37
CZ - Repubblica Ceca 37
IR - Iran 35
VE - Venezuela 34
CH - Svizzera 32
PK - Pakistan 32
UZ - Uzbekistan 31
PH - Filippine 30
MA - Marocco 28
SA - Arabia Saudita 28
CL - Cile 23
CO - Colombia 22
EG - Egitto 19
PE - Perù 19
LT - Lituania 18
MY - Malesia 18
PY - Paraguay 18
AE - Emirati Arabi Uniti 17
BE - Belgio 17
NG - Nigeria 17
AL - Albania 16
DZ - Algeria 14
AZ - Azerbaigian 13
JO - Giordania 13
TN - Tunisia 13
NP - Nepal 11
AU - Australia 9
BG - Bulgaria 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
HU - Ungheria 8
KZ - Kazakistan 8
TW - Taiwan 8
CY - Cipro 7
IL - Israele 7
LV - Lettonia 7
MK - Macedonia 6
QA - Qatar 6
TH - Thailandia 6
UY - Uruguay 6
EE - Estonia 5
ET - Etiopia 5
EU - Europa 5
JM - Giamaica 5
KG - Kirghizistan 5
NO - Norvegia 5
OM - Oman 5
PA - Panama 5
RO - Romania 5
AO - Angola 4
BB - Barbados 4
BY - Bielorussia 4
GE - Georgia 4
GR - Grecia 4
HN - Honduras 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
BH - Bahrain 3
BW - Botswana 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
XK - ???statistics.table.value.countryCode.XK??? 3
BO - Bolivia 2
CG - Congo 2
CR - Costa Rica 2
GA - Gabon 2
Totale 29.918
Città #
Dallas 6.198
Singapore 1.263
Dublin 799
Moscow 757
Ashburn 597
Hefei 556
San Jose 546
Hong Kong 525
Southend 508
Santa Clara 464
Milan 457
Seoul 377
Chandler 311
Siena 307
Los Angeles 295
Munich 278
Ho Chi Minh City 277
Beijing 270
Council Bluffs 265
Rome 225
New York 223
Helsinki 215
Florence 209
Johannesburg 199
Fairfield 180
Lauterbourg 177
Hanoi 175
The Dalles 139
São Paulo 125
Buffalo 100
Houston 96
Princeton 95
Bengaluru 84
Seattle 83
Nuremberg 75
Chicago 74
Orem 69
Woodbridge 69
Shanghai 68
Cambridge 64
Bologna 61
Naples 60
Ann Arbor 59
Redondo Beach 57
Turku 57
Wilmington 57
Tokyo 54
Warsaw 54
Lappeenranta 53
London 52
Frankfurt am Main 48
Rio de Janeiro 47
Toronto 46
Dong Ket 43
Montreal 42
Guangzhou 39
Turin 39
Brescia 38
Abidjan 37
Haiphong 37
Denver 36
Málaga 35
Brooklyn 33
Baghdad 32
Chennai 31
Poplar 31
Mexico City 30
San Diego 30
Piscataway 29
Amsterdam 28
Da Nang 28
Fremont 28
Stockholm 28
Boardman 27
Tashkent 27
Atlanta 26
Mumbai 26
Phoenix 25
Portsmouth 25
Boston 24
Vienna 24
Düsseldorf 22
Manchester 22
San Mateo 22
Washington 22
Biên Hòa 21
Salt Lake City 21
Zurich 21
Genoa 20
Brasília 19
Charlotte 19
Salvador 19
Brno 18
Catania 18
Guarulhos 18
Newark 18
Padova 18
Paris 18
Porto Alegre 18
Trieste 18
Totale 19.749
Nome #
Vo2peak, Ve/VCO2, and Cardiac Remodeling Correlate with Long-Term Cardiovascular Outcome in Heart Failure Patients 1.272
Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect in Athletes: A Study With a Long-Term Follow-Up 832
Antiplatelet and Anticoagulation Therapy in Athletes: A Cautious Compromise… If Possible! 639
A first update on mapping the human genetic architecture of COVID-19 582
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 577
Il test da sforzo cardiopolmonare: uno strumento fondamentale per una prescrizione personalizzata dell’esercizio fisico nei pazienti con malattia cardiovascolare : Cardiopulmonary exercise testing: an essential tool for a tailored exercise prescription in patients with cardiac disease 552
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 513
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 504
Prognostic value of left atrial strain in acute and chronic heart failure: A meta-analysis 465
Genetic mechanisms of critical illness in COVID-19 430
Left Ventricular Mass with Delayed Enhancement as a Predictor of Major Events in Patients with Myocarditis with Preserved Ejection Fraction 428
Pressure-strain loops unveil haemodynamics behind mechanical circulatory support systems 419
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 417
An explainable model of host genetic interactions linked to COVID-19 severity 369
Antirheumatic agents in covid-19: is IL-6 the right target? 360
The loss of left atrial contractile function predicts a worse outcome in HFrEF patients 355
Pathogen-sugar interactions revealed by universal saturation transfer analysis 352
The role of cardiac computed tomography in sports cardiology: back to the future! 327
null 320
Peripheral biomarkers' panel for severe COVID-19 patients 318
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 314
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 302
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 289
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 285
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 285
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 257
Prognostic bioindicators in severe COVID-19 patients 256
Serial KL-6 measurements in COVID-19 patients 248
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 247
The importance of ventilatory thresholds to define aerobic exercise intensity in cardiac patients and healthy subjects 246
Clinician approach to cardiopulmonary exercise testing for exercise prescription in patients at risk of and with cardiovascular disease 240
Left atrial strain by speckle tracking predicts atrial fibrosis in patients undergoing heart transplantation 240
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 237
A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play 231
Causes of sudden cardiac death in young athletes and non-athletes: systematic review and meta-analysis: Sudden cardiac death in the young 228
Ablation therapy for ventricular arrhythmias in patients with LVAD: Multiple faces of an electrophysiological challenge 225
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 223
SARS-CoV-2 in pleural fluid in a kidney transplant patient 219
A multidisciplinary approach for the emergency care of patients with left ventricular assist devices: A practical guide 217
Right ventricular dysfunction in left ventricular assist device candidates: is it time to change our prospective? 216
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 214
Bedside Ultrasound for Hemodynamic Monitoring in Cardiac Intensive Care Unit 209
Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients 207
Detection of cardiac allograft vasculopathy by multi-layer left ventricular longitudinal strain in heart transplant recipients 207
Clinical, echocardiographic and hemodynamic predictors of right heart failure after LVAD placement 204
ACUTE HF score: a new multi-parametric score for the prognostication of acute heart failure 203
Whole-genome sequencing reveals host factors underlying critical COVID-19 201
Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey 198
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol 198
ADONHERS (Aged DONor HEart Rescue by Stress Echo) National Protocol: Recipient's Survival after 10-Year Follow-Up 196
Aortic root/left ventricular diameters golden ratio in competitive athletes 194
Clinical and molecular characterization of COVID-19 hospitalized patients 194
Survival in acute heart failure in intensive cardiac care unit: a prospective study 194
Clinical management of young competitive athletes with premature ventricular beats: A prospective cohort study 194
Cardiogenic shock and acute kidney injury: the rule rather than the exception 193
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 191
Basic and advanced echocardiography in advanced heart failure: an overview 190
Heart transplantation and anti-HLA antibodY: myocardial dysfunction and prognosis - HeartLAy study 185
Right ventricular myocardial work for the prediction of early right heart failure and long-term mortality after left ventricular assist device implant 184
SARS-CoV-2 infection and return to play in junior competitive athletes: is systematic cardiac screening needed? 183
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 177
Left atrial strain as a pre-operative prognostic marker for patients with severe mitral regurgitation 176
Correlation of Left Ventricular Myocardial Work Indices with Invasive Measurement of Stroke Work in Patients with Advanced Heart Failure 173
Left ventricular fibrosis as a main determinant of filling pressures and left atrial function in advanced heart failure 172
How to evaluate resting ECG and imaging in children practising sport: a critical review and proposal of an algorithm for ECG interpretation 172
Cardiopulmonary Fitness and Personalized Exercise Prescription in Patients With Hypertrophic Cardiomyopathy 170
Tricuspid Regurgitation Velocity and Mean Pressure Gradient for the Prediction of Pulmonary Hypertension According to the New Hemodynamic Definition 169
High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab 169
Echocardiography for left ventricular assist device implantation and evaluation: an indispensable tool 165
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 159
Diastolic function in heart transplant: From physiology to echocardiographic assessment and prognosis 157
Dapagliflozin Effects on Cardiac Deformation in Heart Failure and Secondary Clinical Outcome 156
Left ventricular assist device in cardiac amyloidosis: friend or foe? 153
COVID-19 and the burning issue of drug interaction: Never forget the ECG 153
Safe performance of echocardiography during the COVID-19 pandemic: A practical guide 150
Left ventricular assist device and transcatheter edge-to-edge mitral valve repair in advanced heart failure: allies or enemies? 149
Two and Three-Dimensional Echocardiography in Primary Mitral Regurgitation: Practical Hints to Optimize the Surgical Planning 148
Post-acute sequelae of COVID-19: the potential role of exercise therapy in treating patients and athletes returning to play 147
Prediction of congestive state in acute and chronic heart failure: The association between NT-proBNP and left atrial strain and its prognostic value 147
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences 147
Risk stratification in cardiogenic shock: a focus on the available evidence 145
Zero-fluoroscopy catheter ablation of premature ventricular contractions at left coronary cusp near left main coronary artery 142
COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications 140
ANMCO Position Paper: Amyloidosis for the clinical cardiologist. A "clinical primer" from the ANMCO Rare Disease Working Group [Position paper ANMCO: L’amiloidosi per il cardiologo clinico. Un “clinical primer” dell’Area Malattie Rare ANMCO] 138
Case Report: Two Case Reports of Acute Myopericarditis After mRNA COVID-19 Vaccine 138
Maternal Anti-Ro/SSA Autoantibodies and Prolonged PR Interval in a Competitive Athlete: Beyond Training-Induced Electrical Remodeling 138
Usefulness of echocardiography to detect cardiac involvement in COVID-19 patients 135
From Coronary Artery Ectasia to Giant Coronary Artery Aneurysm: Is it Necessary to Follow-Up? 134
Hemodynamic variations and pitfalls during venoarterial extracorporeal membrane oxygenation and left ventricular apical unloading as bridge to heart transplantation 133
Acute coronary syndromes during COVID-19 132
ANMCO Position Paper: Appropriateness of prescribing direct oral anticoagulants in stroke and systemic thromboembolism prevention in adult patients with non-valvular atrial fibrillation 131
Clinical pathway for cardiogenic shock. A proposal from ANMCO Tuscany [Clinical pathway per lo shock cardiogeno. La proposta dell’ANMCO Toscana] 130
ANMCO Position paper: Antithrombotic treatment of patients with atrial fibrillation and acute or chronic coronary syndromes undergoing coronary angioplasty with stent implantation [Position paper ANMCO: Trattamento antitrombotico nei pazienti con fibrillazione atriale e sindromi coronariche acute o croniche sottoposti ad angioplastica coronarica con impianto di stent] 130
COVID-19 in patients with heart failure: the new and the old epidemic 127
ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes 126
The acute effects of an ultramarathon on atrial function and supraventricular arrhythmias in master athletes 125
Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence 123
Insight into Atrial Fibrillation in LVAD Patients: From Clinical Implications to Prognosis 123
Clinical profile and management of patients with acute myocardial infarction admitted to cardiac care units: The EYESHOT-2 registry 122
ANMCO Position Paper: Cardiovascular disease in women - Prevention, diagnosis, treatment and organization of care ANMCO Position Paper: Cardiovascular disease in women - Prevention, diagnosis, treatment and organization of care 122
Totale 24.818
Categoria #
all - tutte 85.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.919


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 0 0 0 0 0 0 0 0 93
2021/20221.223 102 96 72 68 64 81 122 80 57 103 144 234
2022/20231.517 88 139 178 136 98 220 130 137 92 83 88 128
2023/20242.045 93 88 204 172 104 363 561 96 40 79 67 178
2024/20255.896 167 188 468 265 499 687 531 366 516 312 543 1.354
2025/202618.994 924 4.187 3.860 2.069 2.799 582 1.553 478 600 920 788 234
Totale 30.702